You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
7 December 2022
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial
6 December 2022
What’s Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers
2 December 2022
First Patients Dosed in Phase I/II Trial of Enlivex’s Off-the-Shelf Cell Therapy Candidate, AllocetraTM
1 December 2022
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors